GLP-3 RETA (Retatrutide) – Advanced Metabolic Peptide Research
15mg Vial | Ultra-Pure | ≥99% Peptide-Grade Purity
🔬 High-Purity Research Peptide – Synthesized for reproducible laboratory studies
🧪 Verified for Quality – HPLC Tested, COA Provided, Third-Party Tested
📚 Backed by Scientific Literature – Extensive studies on metabolic regulation, weight management, and GLP receptor research
Chemical Information
• Synonyms: Retatrutide, GLP-3 RETA
• Form: Lyophilized powder, 10mg, 20mg, 30mg, 50mg per vial
• Purity: ≥99% (Peptide-grade)
• Storage: Store at 2–8°C in a dry, shaded place
Description
GLP-3 RETA is a next-generation peptide targeting GLP, Glucagon, and GIP receptors for research into metabolic regulation and body composition. Retatrutide has shown preclinical potential to regulate appetite, enhance fat metabolism, and support weight management studies. Its multi-receptor activity makes it a leading candidate for studies alongside other metabolic peptides.
Used in preclinical studies, GLP-3 RETA complements peptides like Tesamorelin, 5 AMINO 1MQ, and MAXX SHRED for enhanced metabolic and fat-loss research protocols.
Research Findings & Scientific Insights
🧪 Metabolic Regulation: Preclinical studies demonstrate effects on glucose homeostasis, appetite control, and energy expenditure.
⚖️ Body Composition: Enhances fat metabolism pathways, supporting lean mass maintenance.
🌐 Multi-Receptor Activity: Triple GLP, GIP and Glucagon receptor activation for synergistic metabolic effects.
Product Assurance
✅ HPLC Verified – Ensuring ≥99% purity
✅ COA Provided – On Request
✅ Manufactured in a GMP-Certified Facility - Developed & Dispatched in the UK
✅ Third-Party Testing Available
✅ Cold Chain Express Delivery – Ensuring Potency & Integrity
⚠️ For Research Use Only
GLP-3 RETA is supplied strictly for scientific research purposes. Not approved for human or veterinary use. Handle with appropriate lab safety procedures.